Many studies have reported that suppression of MHC-I and IFN signaling downregulates inflammation in numerous diseases (e.g., infectious disease, cancer, autoimmune disease) (29–34), highlighting the potential to treat asthma exacerbation by targeting these pathways. Here, IFNA1 is linked to infectious disease.